Jane Street Group, LLC Immunovant, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$27.51 - $27.51 $4.95 Million - $4.95 Million	179,900 New	179,900 $4.95 Million
Q4 2021 Feb 15, 2022	SELL	$7.33 - $9.32 $512,367 - $651,468	-69,900 Reduced 84.83%	12,500 $107,000
Q3 2021 Nov 16, 2021	SELL	$7.01 - $11.37 $46,967 - $76,179	-6,700 Reduced 7.52%	82,400 $716,000
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $837,540 - $1.5 Million	89,100 New	89,100 $942,000

212

66.9M

2.3M

631K

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.